Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.
Identifieur interne : 000460 ( Ncbi/Curation ); précédent : 000459; suivant : 000461Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.
Auteurs : A. Albanese [Italie] ; U. Bonuccelli ; C. Brefel ; K R Chaudhuri ; C. Colosimo ; T. Eichhorn ; E. Melamed ; P. Pollak ; T. Van Laar ; M. ZappiaSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 2001.
English descriptors
- KwdEn :
- Apomorphine (administration & dosage), Apomorphine (diagnostic use), Apomorphine (pharmacology), Corpus Striatum (drug effects), Decision Making, Domperidone (administration & dosage), Domperidone (diagnostic use), Domperidone (pharmacology), Dopamine Agonists (administration & dosage), Dopamine Agonists (diagnostic use), Dopamine Agonists (pharmacology), Dopamine Antagonists (administration & dosage), Dopamine Antagonists (diagnostic use), Dopamine Antagonists (pharmacology), Drug Administration Schedule, Guidelines as Topic, Humans, Levodopa (administration & dosage), Levodopa (diagnostic use), Levodopa (pharmacology), Parkinson Disease (diagnosis), Substantia Nigra (drug effects), Time Factors.
- MESH :
- chemical , administration & dosage : Apomorphine, Domperidone, Dopamine Agonists, Dopamine Antagonists, Levodopa.
- chemical , diagnostic use : Apomorphine, Domperidone, Dopamine Agonists, Dopamine Antagonists, Levodopa.
- chemical , pharmacology : Apomorphine, Domperidone, Dopamine Agonists, Dopamine Antagonists, Levodopa.
- diagnosis : Parkinson Disease.
- drug effects : Corpus Striatum, Substantia Nigra.
- Decision Making, Drug Administration Schedule, Guidelines as Topic, Humans, Time Factors.
Abstract
Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders.
PubMed: 11295770
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003D91
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003D91
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003D80
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000460
Links to Exploration step
pubmed:11295770Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.</title>
<author><name sortKey="Albanese, A" sort="Albanese, A" uniqKey="Albanese A" first="A" last="Albanese">A. Albanese</name>
<affiliation wicri:level="1"><nlm:affiliation>Istituto di Neurologia, Università Cattolica, Milano, Italy. alberto.albanese@rm.unicatt.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Neurologia, Università Cattolica, Milano</wicri:regionArea>
<wicri:noRegion>Milano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, U" sort="Bonuccelli, U" uniqKey="Bonuccelli U" first="U" last="Bonuccelli">U. Bonuccelli</name>
</author>
<author><name sortKey="Brefel, C" sort="Brefel, C" uniqKey="Brefel C" first="C" last="Brefel">C. Brefel</name>
</author>
<author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K R" last="Chaudhuri">K R Chaudhuri</name>
</author>
<author><name sortKey="Colosimo, C" sort="Colosimo, C" uniqKey="Colosimo C" first="C" last="Colosimo">C. Colosimo</name>
</author>
<author><name sortKey="Eichhorn, T" sort="Eichhorn, T" uniqKey="Eichhorn T" first="T" last="Eichhorn">T. Eichhorn</name>
</author>
<author><name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
</author>
<author><name sortKey="Pollak, P" sort="Pollak, P" uniqKey="Pollak P" first="P" last="Pollak">P. Pollak</name>
</author>
<author><name sortKey="Van Laar, T" sort="Van Laar, T" uniqKey="Van Laar T" first="T" last="Van Laar">T. Van Laar</name>
</author>
<author><name sortKey="Zappia, M" sort="Zappia, M" uniqKey="Zappia M" first="M" last="Zappia">M. Zappia</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11295770</idno>
<idno type="pmid">11295770</idno>
<idno type="wicri:Area/PubMed/Corpus">003D91</idno>
<idno type="wicri:Area/PubMed/Curation">003D91</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003D80</idno>
<idno type="wicri:Area/Ncbi/Merge">000460</idno>
<idno type="wicri:Area/Ncbi/Curation">000460</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.</title>
<author><name sortKey="Albanese, A" sort="Albanese, A" uniqKey="Albanese A" first="A" last="Albanese">A. Albanese</name>
<affiliation wicri:level="1"><nlm:affiliation>Istituto di Neurologia, Università Cattolica, Milano, Italy. alberto.albanese@rm.unicatt.it</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto di Neurologia, Università Cattolica, Milano</wicri:regionArea>
<wicri:noRegion>Milano</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bonuccelli, U" sort="Bonuccelli, U" uniqKey="Bonuccelli U" first="U" last="Bonuccelli">U. Bonuccelli</name>
</author>
<author><name sortKey="Brefel, C" sort="Brefel, C" uniqKey="Brefel C" first="C" last="Brefel">C. Brefel</name>
</author>
<author><name sortKey="Chaudhuri, K R" sort="Chaudhuri, K R" uniqKey="Chaudhuri K" first="K R" last="Chaudhuri">K R Chaudhuri</name>
</author>
<author><name sortKey="Colosimo, C" sort="Colosimo, C" uniqKey="Colosimo C" first="C" last="Colosimo">C. Colosimo</name>
</author>
<author><name sortKey="Eichhorn, T" sort="Eichhorn, T" uniqKey="Eichhorn T" first="T" last="Eichhorn">T. Eichhorn</name>
</author>
<author><name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
</author>
<author><name sortKey="Pollak, P" sort="Pollak, P" uniqKey="Pollak P" first="P" last="Pollak">P. Pollak</name>
</author>
<author><name sortKey="Van Laar, T" sort="Van Laar, T" uniqKey="Van Laar T" first="T" last="Van Laar">T. Van Laar</name>
</author>
<author><name sortKey="Zappia, M" sort="Zappia, M" uniqKey="Zappia M" first="M" last="Zappia">M. Zappia</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Apomorphine (administration & dosage)</term>
<term>Apomorphine (diagnostic use)</term>
<term>Apomorphine (pharmacology)</term>
<term>Corpus Striatum (drug effects)</term>
<term>Decision Making</term>
<term>Domperidone (administration & dosage)</term>
<term>Domperidone (diagnostic use)</term>
<term>Domperidone (pharmacology)</term>
<term>Dopamine Agonists (administration & dosage)</term>
<term>Dopamine Agonists (diagnostic use)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Antagonists (administration & dosage)</term>
<term>Dopamine Antagonists (diagnostic use)</term>
<term>Dopamine Antagonists (pharmacology)</term>
<term>Drug Administration Schedule</term>
<term>Guidelines as Topic</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (diagnostic use)</term>
<term>Levodopa (pharmacology)</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Substantia Nigra (drug effects)</term>
<term>Time Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Apomorphine</term>
<term>Domperidone</term>
<term>Dopamine Agonists</term>
<term>Dopamine Antagonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Apomorphine</term>
<term>Domperidone</term>
<term>Dopamine Agonists</term>
<term>Dopamine Antagonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Apomorphine</term>
<term>Domperidone</term>
<term>Dopamine Agonists</term>
<term>Dopamine Antagonists</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Corpus Striatum</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Decision Making</term>
<term>Drug Administration Schedule</term>
<term>Guidelines as Topic</term>
<term>Humans</term>
<term>Time Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000460 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000460 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:11295770 |texte= Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:11295770" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
This area was generated with Dilib version V0.6.23. |